Toll Free: 1-888-928-9744

Global Immunotherapy Drugs Market Professional Survey Report 2016

Published: Jun 7, 2016 | Pages: 114 | Publisher: QYResearch | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

This report mainly covers the following

Product types including
mAbs Immune checkpoint inhibitors Vaccines Non-specific immunotherapies
The segment applications including
Hospital use Clinic use School use Others
Segment regions including (the separated region report can also be offered)
North America Europe Japan China Southeast Asia India
The players list (Partly, Players you are interested in can also be added)
Roche Merck Novartis GlaxoSmithKline (GSK) Amgen Bristol-Myers Squibb Eli Lilly and Company Celgene Seattle Genetics Spectrum Pharmaceuticals AbbVie Inc. Amgen Inc. Bristol-Myers Squibb Company (BMS) F. Hoffmann-La Roche AG Johnson & Johnson Private Ltd. Merck & Co. Inc.? AB Science AstraZeneca Baxter Bayer Biotech Pharmaceutical? Daiichi Sankyo Immunomedics Sandoz TG Therapeutics Takeda With 26 top producers. Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc. More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
 Table of Contents
1 Industry Overview of Immunotherapy Drugs 1.1 Definition and Specifications of Immunotherapy Drugs 1.1.1 Definition of Immunotherapy Drugs 1.1.2 Specifications of Immunotherapy Drugs 1.2 Classification of Immunotherapy Drugs 1.2.1 mAbs 1.2.2 Immune checkpoint inhibitors 1.2.3 Vaccines 1.2.4 Non-specific immunotherapies 1.3 Applications of Immunotherapy Drugs 1.3.1 Hospital use 1.3.2 Clinic use 1.3.3 School use 1.3.4 Others 1.4 Industry Chain Structure of Immunotherapy Drugs 1.5 Industry Overview and Major Regions Status of Immunotherapy Drugs 1.5.1 Industry Overview of Immunotherapy Drugs 1.5.2 Global Major Regions Status of Immunotherapy Drugs 1.6 Industry Policy Analysis of Immunotherapy Drugs 1.7 Industry News Analysis of Immunotherapy Drugs 2 Manufacturing Cost Structure Analysis of Immunotherapy Drugs 2.1 Raw Material Suppliers and Price Analysis of Immunotherapy Drugs 2.2 Equipment Suppliers and Price Analysis of Immunotherapy Drugs 2.3 Labor Cost Analysis of Immunotherapy Drugs 2.4 Other Costs Analysis of Immunotherapy Drugs 2.5 Manufacturing Cost Structure Analysis of Immunotherapy Drugs 2.6 Manufacturing Process Analysis of Immunotherapy Drugs 3 Technical Data and Manufacturing Plants Analysis of Immunotherapy Drugs 3.1 Capacity and Commercial Production Date of Global Immunotherapy Drugs Major Manufacturers in 2015 3.2 Manufacturing Plants Distribution of Global Immunotherapy Drugs Major Manufacturers in 2015 3.3 R&D Status and Technology Source of Global Immunotherapy Drugs Major Manufacturers in 2015 3.4 Raw Materials Sources Analysis of Global Immunotherapy Drugs Major Manufacturers in 2015 4 Global Immunotherapy Drugs Overall Market Overview 4.1 2011-2016E Overall Market Analysis 4.2.1 2011-2015 Global Immunotherapy Drugs Capacity and Growth Rate Analysis 4.2.2 2015 Immunotherapy Drugs Capacity Analysis (Company Segment) 4.3 Sales Analysis 4.3.1 2011-2015 Global Immunotherapy Drugs Sales and Growth Rate Analysis 4.3.2 2015 Immunotherapy Drugs Sales Analysis (Company Segment) 4.4 Sales Price Analysis 4.4.1 2011-2015 Global Immunotherapy Drugs Sales Price 4.4.2 2015 Immunotherapy Drugs Sales Price Analysis (Company Segment) 4.5 Gross Margin Analysis 4.5.1 2011-2015 Global Immunotherapy Drugs Gross Margin 4.5.2 2015 Immunotherapy Drugs Gross Margin Analysis (Company Segment) 5 Immunotherapy Drugs Regional Market Analysis 5.1 North America Immunotherapy Drugs Market Analysis 5.1.1 North America Immunotherapy Drugs Market Overview 5.1.2 North America 2011-2016E Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis 5.1.3 North America 2011-2016E Immunotherapy Drugs Sales Price Analysis 5.1.4 North America 2015 Immunotherapy Drugs Market Share Analysis 5.2 Europe Immunotherapy Drugs Market Analysis 5.2.1 Europe Immunotherapy Drugs Market Overview 5.2.2 Europe 2011-2016E Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis 5.2.3 Europe 2011-2016E Immunotherapy Drugs Sales Price Analysis 5.2.4 Europe 2015 Immunotherapy Drugs Market Share Analysis 5.3 Japan Immunotherapy Drugs Market Analysis 5.3.1 Japan Immunotherapy Drugs Market Overview 5.3.2 Japan 2011-2016E Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis 5.3.3 Japan 2011-2016E Immunotherapy Drugs Sales Price Analysis 5.3.4 Japan 2015 Immunotherapy Drugs Market Share Analysis 5.4 China Immunotherapy Drugs Market Analysis 5.4.1 China Immunotherapy Drugs Market Overview 5.4.2 China 2011-2016E Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis 5.4.3 China 2011-2016E Immunotherapy Drugs Sales Price Analysis 5.4.4 China 2015 Immunotherapy Drugs Market Share Analysis 5.5 Southeast Asia Immunotherapy Drugs Market Analysis 5.5.1 Southeast Asia Immunotherapy Drugs Market Overview 5.5.2 Southeast Asia 2011-2016E Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis 5.5.3 Southeast Asia 2011-2016E Immunotherapy Drugs Sales Price Analysis 5.5.4 Southeast Asia 2015 Immunotherapy Drugs Market Share Analysis 5.6 India Immunotherapy Drugs Market Analysis 5.6.1 India Immunotherapy Drugs Market Overview 5.6.2 India 2011-2016E Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis 5.6.3 India 2011-2016E Immunotherapy Drugs Sales Price Analysis 5.6.4 India 2015 Immunotherapy Drugs Market Share Analysis 6 Global 2011-2016E Immunotherapy Drugs Segment Market Analysis (by Type) 6.1 Global 2011-2016E Immunotherapy Drugs Sales by Type 6.2 Different Types Immunotherapy Drugs Product Interview Price Analysis 6.3 Different Types Immunotherapy Drugs Product Driving Factors Analysis 6.3.1 mAbs Immunotherapy Drugs Growth Driving Factor Analysis 6.3.2 Immune checkpoint inhibitors Immunotherapy Drugs Growth Driving Factor Analysis 6.3.3 Vaccines Immunotherapy Drugs Growth Driving Factor Analysis 6.3.4 Non-specific immunotherapies Immunotherapy Drugs Growth Driving Factor Analysis 7 Global 2011-2016E Immunotherapy Drugs Segment Market Analysis (by Application) 7.1 Global 2011-2016E Consumption by Application 7.2 Different Application Product Interview Price Analysis 7.3 Different Application Product Driving Factors Analysis 7.3.1 Hospital use Immunotherapy Drugs Growth Driving Factor Analysis 7.3.2 Clinic use Immunotherapy Drugs Growth Driving Factor Analysis 7.3.3 School use Immunotherapy Drugs Growth Driving Factor Analysis 7.3.4 Others Immunotherapy Drugs Growth Driving Factor Analysis 8 Major Manufacturers Analysis of Immunotherapy Drugs 8.1 Roche 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.3 Roche 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 Roche 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.2 Merck 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.3 Merck 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 Merck 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.3 Novartis 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.3 Novartis 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 Novartis 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.4 GlaxoSmithKline (GSK) 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.3 GlaxoSmithKline (GSK) 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 GlaxoSmithKline (GSK) 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.5 Amgen 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.3 Amgen 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 Amgen 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.6 Bristol-Myers Squibb 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.3 Bristol-Myers Squibb 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 Bristol-Myers Squibb 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.7 Eli Lilly and Company 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.3 Eli Lilly and Company 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 Eli Lilly and Company 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.8 Celgene 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.3 Celgene 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 Celgene 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.9 Seattle Genetics 8.9.1 Company Profile 8.9.2 Product Picture and Specifications 8.9.3 Seattle Genetics 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.9.4 Seattle Genetics 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.10 Spectrum Pharmaceuticals 8.10.1 Company Profile 8.10.2 Product Picture and Specifications 8.10.3 Spectrum Pharmaceuticals 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.10.4 Spectrum Pharmaceuticals 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.11 AbbVie Inc. 8.11.1 Company Profile 8.11.2 Product Picture and Specifications 8.11.3 AbbVie Inc. 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.11.4 AbbVie Inc. 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.12 Amgen Inc. 8.12.1 Company Profile 8.12.2 Product Picture and Specifications 8.12.3 Amgen Inc. 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.12.4 Amgen Inc. 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.13 Bristol-Myers Squibb Company (BMS) 8.13.1 Company Profile 8.13.2 Product Picture and Specifications 8.13.3 Bristol-Myers Squibb Company (BMS) 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.13.4 Bristol-Myers Squibb Company (BMS) 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.14 F. Hoffmann-La Roche AG 8.14.1 Company Profile 8.14.2 Product Picture and Specifications 8.14.3 F. Hoffmann-La Roche AG 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.14.4 F. Hoffmann-La Roche AG 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.15 Johnson & Johnson Private Ltd. 8.15.1 Company Profile 8.15.2 Product Picture and Specifications 8.15.3 Johnson & Johnson Private Ltd. 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.15.4 Johnson & Johnson Private Ltd. 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.16 Merck & Co. Inc.? 8.16.1 Company Profile 8.16.2 Product Picture and Specifications 8.16.3 Merck & Co. Inc.? 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.16.4 Merck & Co. Inc.? 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.17 AB Science 8.17.1 Company Profile 8.17.2 Product Picture and Specifications 8.17.3 AB Science 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.17.4 AB Science 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.18 AstraZeneca 8.18.1 Company Profile 8.18.2 Product Picture and Specifications 8.18.3 AstraZeneca 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.18.4 AstraZeneca 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.19 Baxter 8.19.1 Company Profile 8.19.2 Product Picture and Specifications 8.19.3 Baxter 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.19.4 Baxter 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.20 Bayer 8.20.1 Company Profile 8.20.2 Product Picture and Specifications 8.20.3 Bayer 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.20.4 Bayer 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.21 Biotech Pharmaceutical? 8.21.1 Company Profile 8.21.2 Product Picture and Specifications 8.21.3 Biotech Pharmaceutical? 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.21.4 Biotech Pharmaceutical? 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.22 Daiichi Sankyo 8.22.1 Company Profile 8.22.2 Product Picture and Specifications 8.22.3 Daiichi Sankyo 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.22.4 Daiichi Sankyo 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.23 Immunomedics 8.23.1 Company Profile 8.23.2 Product Picture and Specifications 8.23.3 Immunomedics 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.23.4 Immunomedics 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.24 Sandoz 8.24.1 Company Profile 8.24.2 Product Picture and Specifications 8.24.3 Sandoz 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.24.4 Sandoz 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.25 TG Therapeutics 8.25.1 Company Profile 8.25.2 Product Picture and Specifications 8.25.3 TG Therapeutics 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.25.4 TG Therapeutics 2015 Immunotherapy Drugs Business Region Distribution Analysis 8.26 Takeda 8.26.1 Company Profile 8.26.2 Product Picture and Specifications 8.26.3 Takeda 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.26.4 Takeda 2015 Immunotherapy Drugs Business Region Distribution Analysis 9 Development Trend of Analysis of Market 9.1 Global Market Trend Analysis 9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast 9.1.2 Global 2016-2021 Sales Price Forecast 9.1.3 Global 2016-2021 Gross Margin Forecast 9.2 Regional Market Trend 9.2.1 North America 2016-2021 Immunotherapy Drugs Consumption Forecast 9.2.2 Europe 2016-2021 Immunotherapy Drugs Consumption Forecast 9.2.3 Japan 2016-2021 Immunotherapy Drugs Consumption Forecast 9.2.4 China 2016-2021 Immunotherapy Drugs Consumption Forecast 9.2.5 Southeast Asia 2016-2021 Immunotherapy Drugs Consumption Forecast 9.2.6 India 2016-2021 Immunotherapy Drugs Consumption Forecast 9.3 Market Trend (Product type) 9.4 Market Trend (Application) 10 Immunotherapy Drugs Marketing Model Analysis 10.1 Immunotherapy Drugs Regional Marketing Model Analysis 10.2 Immunotherapy Drugs International Trade Model Analysis 10.3 Traders or Distributors with Contact Information of Immunotherapy Drugs by Regions 10.4 Immunotherapy Drugs Supply Chain Analysis 11 Consumers Analysis of Immunotherapy Drugs 11.1 Consumer 1 Analysis 11.2 Consumer 2 Analysis 11.3 Consumer 3 Analysis 11.4 Consumer 4 Analysis … 12 New Project Investment Feasibility Analysis of Immunotherapy Drugs 12.1 New Project SWOT Analysis of Immunotherapy Drugs 12.2 New Project Investment Feasibility Analysis of Immunotherapy Drugs 13 Conclusion of the Global Immunotherapy Drugs Market Professional Survey Report 2016

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global microcontroller market is estimated to be valued at USD 26.9 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing demand in key application areas such as automotive, consumer electronics and healthcare is expected to

Read More...

Global automotive coatings market size is likely to be valued at USD 27.7 billion by 2022; as per a new research report by Radiant Insights, Inc. Vehicle aesthetics, UV radiation and temperature variation protection and enhance durability are certain

Read More...

Global automotive ECU market is projected to be valued at USD 45.98 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising use in infotainment systems coupled with high deployment in electric vehicles applications is expected

Read More...

Global contact lenses market size is estimated to reach USD 12.5 billion by 2020, according to a new industry report by Radiant Insights, Inc. Growing number of ophthalmic disorder observed in global population especially children is likely to drive

Read More...

Global coated fabrics market size forecast is estimated at USD 22.57 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing production of seat covers & airbags for automobile applications is likely to favor market growth.

Read More...
Choose License Type
Single User - US $3500
Multi User - US $7000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify